Resistin Modulates Low-Density Lipoprotein Cholesterol Uptake in Human Placental Explants via PCSK9. 2022

Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
Department of Immunobiochemistry, Instituto Nacional de Perinatologia, Mexico City, Mexico.

Maternal metabolic status influences pregnancy and, consequently, the perinatal outcome. Resistin is a pro-inflammatory adipokine predominantly expressed and secreted by mononuclear cells, adipose tissue, and placental trophoblastic cells during pregnancy. Recently, we reported an inverse association between maternal resistin levels and fetal low-density lipoprotein cholesterol (LDL-C). Then, in this work, we used a human placental explant model and the trophoblast cell line JEG-3 to evaluate whether resistin affects placental LDL-C uptake. Resistin exposure induced the transcription factor SREBP-2, LDLR, and PCSK9 mRNA expression, and changes at the protein level were confirmed by immunohistochemistry and Western blot. However, for LDLR, the changes were not consistent between mRNA and protein levels. Using a labeled LDL-cholesterol (BODIPY FL LDL), uptake assay demonstrated that the LDL-C was significantly decreased in placental explants exposed to a high dose of resistin and a lesser extent in JEG-3 cells. In summary, resistin induces PCSK9 expression in placental explants and JEG-3 cells, which could be related to negative regulation of the LDLR by lysosomal degradation. These findings suggest that resistin may significantly regulate the LDL-C uptake and transport from the maternal circulation to the fetus, affecting its growth and lipid profile.

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071449 Proprotein Convertase 9 A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS. NARC-1 Protein,Neural Apoptosis-Regulated Convertase 1,Proprotein Convertase, Subtilisin-Kexin Type 9,Convertase 9, Proprotein,NARC 1 Protein,Neural Apoptosis Regulated Convertase 1,Proprotein Convertase, Subtilisin Kexin Type 9
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D052243 Resistin A 12-kDa cysteine-rich polypeptide hormone secreted by FAT CELLS in the ADIPOSE TISSUE. It is the founding member of the resistin-like molecule (RELM) hormone family. Resistin suppresses the ability of INSULIN to stimulate cellular GLUCOSE uptake. Adipocyte Cysteine-Rich Secreted Protein FIZZ3,Adipocyte Cysteine Rich Secreted Protein FIZZ3

Related Publications

Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
January 2016, PloS one,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
April 2014, Clinica chimica acta; international journal of clinical chemistry,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
August 2017, Internal medicine journal,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
December 2013, Current opinion in lipidology,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
November 1990, Journal of neurosurgery,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
January 2019, Circulation research,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
November 2020, JAMA cardiology,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
October 2018, Cardiovascular research,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
June 2013, Circulation,
Sonia Nava-Salazar, and Arturo Flores-Pliego, and Giovanni Pérez-Martínez, and Sandra Parra-Hernández, and America Vanoye-Carlo, and Francisco Ibarguengoitia-Ochoa, and Otilia Perichart-Perera, and Enrique Reyes-Muñoz, and Juan Mario Solis-Paredes, and Salvador Espino Y Sosa, and Guadalupe Estrada-Gutierrez
October 2017, JAMA cardiology,
Copied contents to your clipboard!